All infants under 1001 gms were studied prospectively with ECHO within 24 hrs of admission to the Stanford ICN between 1/1/80 and 6/30/83. They were re-evaluated at least twice weekly, and scored by Papille's classification for ICH and for atrophy and hydrocephalus (HC). Of the 150 infants, 92 (61%) were discharged and examined yearly. Seven were excluded (4 deaths, 1 encephalocele, 1 lost to followup, 1 late non-neonatal neurologic iniurv).
--have more abnormal neurodevelopmental (ND) exams, these infants still have good potential for normal neurological function (74%). However, infants with Grade 111 & IV ICH or isolated atrophy and/or HC may have a poorer prognosis, with no normal exams. Infants with a normal ECHO but an abnormal exam had low birth weights when compared to those with a normal ND exam and also had serious complications of Candida sepsis (3), asphyxia (I), hypothyroidism (I), pneumonia (I), and histiocytosis X (1).
WEIGHT GAIN AND SERUM BILIRUBIN IN NEXi EOIWS WITH RD5
1508 TREATED WITH PANCURONIUM BROMIDE, Jose Saraiva, Rosado, Michael F. Epstein, ~e p m n t o f a t r i c s ,
Harvard M e d i c a l h m~f i , MA.
In order to examine the effect of pancuroniun brcmide (PBr)cn~ b d y weight and sennn bilirubin, we retrospectively reviewed the charts of 100 infants with RC6 treated with mechanical ventilation. PBr was ordered according to each physician's judgment and was used in 51 infants. Both groups w r e similar in gestational age, (30.5k3.5 (PBr) vs . 30.1+2.8wk) , male/female distribution, and survival, but patients in the PBr group had higher birth wight (1680280 vs. 1400+50g. p< .05) . Infants treated with PBr gained weight during the first three days and showd a larger A wt (daily -birth weight) than the control group during the first week (PBr, +42?14g vs. noPBr, p<0.01) . Edema was present in 27 PBr treated infants and in 13 of those not treated with PBr (p<0,05). In addition, hyperbilirubinemia was more severe and more prolonged in patients treated with PBr. The t m groups had similar serum bilirubin on days 1 to 5 but serum bilirubin was significantly greater in the treated group on days 6 to 10 (d. 6 PBr 10.5k0.6 vs. noPBr 8.62 0.4 mg/dl, p.02).
The use of PBr was associated with edema, excessive weight gain in the first week of life, and a higher, more prolonged peak of serum bilirubin. These findings remained valid when subgroups matched for severity of hypoxia on day one were examined in order to control for severity of underlying lung disease. . . 179 infants with BPD and 112'matched controls were compared in terms of perinatal factors and long-term outcome (1-8 yrs).
Perinatal factors significantly (p < .001) more common in cases were, gestational agek29 weeks, hyaline membrane disease, episodes of hypoxia and acidosis, interstitial emphysema, pneumothorax, patent ductus arteriosus, long duration of assisted ventilation, episodes of endotracheal tube plugging, atelectasis, post extubation airway obstruction,),lO blood transfusions and the need for parenteral nutrition. 20 cases and 1 control (p <.001) died after discharge from hospital. Significant differences in outcome (p < .002) included increased frequency of lower respiratory illness, rehospitalization during the first year of life, abnormal physical findings on chest exam, growth deficits and the occurrence of retrolental fibroplasia. Neurodevelopmental outcomes, hearing and speech disorders, were more frequent in cases, but differences were not significant. 24/99 (24.2%) of cases and 7/49 (14.3%) of controls had cognitive delays, 28/141 (19.9%) or cases and 8/66 (12.1%) of controls had abnormalities on the Test of Gross Motor and reflex development, and 15/141 (10.6%) of cases and 5/66 (7.6%) of controls had cerebral palsy. Infants with BPD had higher post discharge mortality and morbidity rates in some areas, but differences in neurodevelopmental outcome were not significantly different in the two groups. Bilirubin (B) toxicity was investigated in 2 neural cell lines NBRlOA and N115 using a quantitative dye assay (MTT) as a measure of cell viability and 3H-Thymidine incorporation as a measure of DNA synthesis. The c e l l s are adapted t o grow in a protein free medium. Bilirubin concentration varying between 0.3 and 0.003 mM a t bilirubin/albumin molar r a t i o (B/A) of 0.5 t o 1.5 are introduced t o the media and incubated f o r 2 and 24 hours. MTT (0.5 mg/ ml) and/or 3H-Thymidine ( 1 uCi/dish) are added and incubated f o r a further 2 hours. Short exposures to B even up to a B/A of 1.5 showed no evidence of toxicity using both assays. After a 24 hour exposure t o B, a decrease in cell viability and 3~-~hymidine incorporation was detected a t B/A of 0.8 when B was 0.1 mM or higher, whereas a t lower B a t t h i s molar r a t i o showed no deleterous effect. A t B/A of 1.5 and B of 0.3 mM the decrease in viab i l i t y was 90% and only 20% when B was 0.025 mM f o r NBRlOA. N115 followed a similar but less dramatic response. The concentration effect i s more evident in the 3~-~hymidine studies. A t B/A of 2.5 and B of 0.075 mM or higher, there were both cell k i l l (decrease in DNA levels) and inhibition of 3~ incorporation (decrease in specific a c t i v i t y ) . When B i s reduced t o 0.03 mM, even a t B/A of 1.5 there was l i t t l e or no cell death (no change in DNA l e v e l s ) , but decrease in DNA synthesis (42% decrease in specific a c t i v i t y ) s t i l l existed. Results showed viability and function of these neural cell lines i s dependent not only on B/A but also on absolute concentrations of B, and time of exposure. Ascending aortic blood flow was determined in 6 healthyneonates by range-gated pulsed Doppler technique in the 1st 72 hrs. of life. None of the infants had evidence of structural heart disease or patent ductus arteriosus by 2-D Echo. and all were AGA. The descendins aorta was visualized by 2-D Echo-from a subcostal view and Doppler spectral waveforms were obtained within the ascending aorta. Mean flow velocity during systole was determined by digitizing and integrating the area under the Doppler flow during 3 consecutive systolic intervals with a microsonics computer. Ascending aortic blood flow during systole was calculated by using the formu1a:mean flow velocity x cross-sectional area of the aorta. Ascending aortic blood flow per minute was computed by the formula: systolic ascending aortic blood flow x heart rate. Heart rate was obtained by simultaneously recorded EKG. Mean ascending aortic blood flow was 187f17 ml/min/kg for these 6 neonates. These results are comparable to historical standards for systemic blood flow as determined by the thermodilution and Fick principle derived systemic blood flow. Our study confirms that range-gated pulsed Doppler technique offers a reliable method for non-invasive determination of ascending aortic blood flow. ~easurement of amniotic fluid PG is often used to assess fetal lung maturation. We documented three cases of chorioamnionitis where PG was present despite L/S ratios indicative of pulmonary immaturity. In one case PG was present in a vaginal pool specimen yet absent in a specimen obtained via amniocentesis. We hypothesized that bacterial organisms present may be responsible for the production of PG. E. coli isolated from a niotic fluid and neonatal blood was cultured in 'i?
RANGE-GATED PULSED

BACTERIA CAUSING A FALSE POSITIVE TEST FOR
broth. One ml of 10 colony forming units (CFU) per ml of E. coli was added to 4 ml of broth. One ml samples were removed at 0, 2, 3, and 4 hours and frozen at -65OC until phospholipid analysis was performed. A sample of broth containing no bacteria served as control. Specimens were analyzed for the presence of PG by a one dimensional thin-layer chromatographic (TLC) method. Postive test results were confirmed by two dimensional TLC. PG was present in cultured specimens at 3 and 4 hours incubation (270 x lo6 and 4000 x lo6 CFU, respectively). Broth alone and at 0 and 2 hours (2 x lo6 and 110 x lo6 CFU) contained no detectable PG. It appeared that more PG was present in the specimen incubated the longest. We conclude that bacteria regarded as normal flora can produce PG in detectable amounts and patients with amniotic fluid samples contaminated by growing bacteria may have detectable PG secondary to bacterial rather than fetal production of PG. These observations may weaken the usefulness of PG detection as predictive of lung maturity in patients with amniotic fluid samples contaminated by bacteria.
